Question 1

What are the main structural components of enzyme-linked receptors?

Accepted Answer

Enzyme-linked receptors contain transmembrane helices connecting an extracellular ligand-binding domain to a cytosolic domain that acts as an enzyme or associates with one. The enzyme component can be a kinase, phosphatase, or guanylyl cyclase. This dual-domain architecture allows these receptors to bind signaling molecules externally and catalyze intracellular phosphorylation or other enzymatic reactions, making them effective drug targets for cell division, differentiation, and immune responses.

Question 2

How do receptor tyrosine kinases activate downstream signaling?

Accepted Answer

Receptor tyrosine kinases bind growth factors and undergo conformational changes leading to receptor dimerization. Once dimerized, one receptor phosphorylates tyrosine residues on the other. These phosphorylated tyrosines then bind and phosphorylate target proteins, relaying the signal downstream through a cascade of phosphorylation events that activate mitogen-activated protein kinases essential for gene transcription and cell proliferation.

Question 3

What are the different types of enzyme-linked receptors and their functions?

Accepted Answer

Major enzyme-linked receptor types include receptor tyrosine kinases that phosphorylate tyrosines on signaling proteins; cytokine receptors that associate with Janus kinases to phosphorylate STATs; receptor serine/threonine kinases involved in angiogenesis and bone development; receptor tyrosine phosphatases that remove phosphates to regulate cell growth; and receptor guanylyl cyclases that convert GTP to cyclic GMP for cardiovascular signaling.

Question 4

How do drugs target enzyme-linked receptors?

Accepted Answer

Drugs can target enzyme-linked receptors at two main sites: the extracellular ligand-binding domain or the enzymatic domain itself. Ligand-binding drugs like becaplermin bind the receptor's external domain to activate it. Kinase inhibitors like imatinib and erlotinib directly block the enzymatic domain, preventing phosphorylation of target proteins and halting cancer cell multiplication or other pathological signaling cascades.

Question 5

What role do cytokine receptors play in immune and growth responses?

Accepted Answer

Cytokine receptors associate with intracellular tyrosine kinases such as Janus kinase, which phosphorylate signal transducers and activators of transcription downstream. Phosphorylated STATs translocate to the nucleus to regulate gene transcription. Ligands like interferons and colony-stimulating factors activate these receptors, generating immune responses and stimulating cell growth and differentiation essential for immune cell production.

Question 6

How do receptor guanylyl cyclases regulate cardiovascular function?

Accepted Answer

Receptor guanylyl cyclases convert GTP into cyclic GMP, a second messenger mediating signaling pathways. These receptors are activated by natriuretic peptides released by cardiac cells, such as atrial natriuretic peptide and B-type natriuretic peptide. This signaling lowers blood pressure, reduces cardiac hypertrophy, and initiates bone growth, making these receptors valuable targets for treating congestive heart failure and other cardiovascular diseases.

Question 7

What clinical applications use enzyme-linked receptor drugs?

Accepted Answer

Clinical applications include becaplermin for healing diabetic foot ulcers, imatinib and erlotinib for cancer therapy, aldesleukin for melanoma and renal cell carcinoma, filgrastim for neutropenia, dibotermin alfa for acute tibia fractures, and nesiritide or sacubitril for congestive heart failure. These drugs exploit enzyme-linked receptor mechanisms to treat cancer, immune deficiencies, bone disorders, and cardiovascular diseases.

מנגנון מתמר: קולטנים קשורי אנזים

Browse More Videos